Glenmark Becomes The FirstPharmaceutical Company ToLaunch Teneligliptin + PioglitazoneFixed-Dose Combination Drug ForType 2 Diabetes In India

Glenmark Becomes The FirstPharmaceutical Company ToLaunch Teneligliptin + PioglitazoneFixed-Dose Combination Drug ForType 2 Diabetes In India

By, Admin 27 April 2022

The Innovative Fixed-Dose Combination Will Help Improving The Glycemic ControlAmong Adult Patients With Insulin Resistance, Those Whose Diabetes Is UncontrolledBy Metformin; And Also Those Who Require Addition Of Teneliglitptin AndPioglitazone As Separate Drugs. Launched Under The Brand Name Zita Plus Pio, TheDrug Will Increase The Accessibility Of Quality Drug For Effective DiabetesManagement.Glenmark PharmaceuticalsLimited (Glenmark), AnInnovation-Driven GlobalPharmaceutical Company HasLaunched A Novel Fixed-DoseCombination (Fdc) Of A WidelyUsed Dpp4 Inhibitor (DipeptidylPeptidase 4 Inhibitor),Teneligliptin, With Pioglitazone. This Is The Only Available Dpp4 And Glitazone Combination Brand In India For Adults With Uncontrolled Type 2 Diabetes. GlenmarkHas Launched This Fdc Under The Brand Name Zita Plus Pio, Which ContainsTeneligliptin (20 Mg) + Pioglitazone (15 Mg), To Be Taken Once A Day.Commenting On The Development, Alok Malik, Group Vice President & Head, IndiaFormulations

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!